Fenofibrate for Prevention of DR Worsening
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetic Retinopathy
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized, double-masked, placebo-controlled clinical trialMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04661358
- Collaborators
- National Institutes of Health (NIH)
- National Eye Institute (NEI)
- Juvenile Diabetes Research Foundation
- Roche Pharma AG
- The Leona M. and Harry B. Helmsley Charitable Trust
- Investigators
- Study Chair: Emily Y Chew, MD National Institutes of Health (NIH)